A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 32
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : NGM
Long Form : norgestimate
No. Year Title Co-occurring Abbreviation
2016 UPLC-MS/MS assay for the simultaneous determination of ethinyl estradiol, norgestimate and 17-Desacetyl norgestimate at low pg/mL in human plasma. BE, DNGM, IS
2014 A comparison of multiphasic oral contraceptives containing norgestimate or desogestrel in acne treatment: a randomized trial. DSG, EE, OCs
2014 Comparison of the impact of four generations of progestins on hemostatic variables. COCs, DRSP, FVIII, PAI-1
2014 Epidemiology of hormonal contraceptives-related venous thromboembolism. COCs, EE, GSD, VTE
2011 The effect of atazanavir/ritonavir on the pharmacokinetics of an oral contraceptive containing ethinyl estradiol and norgestimate in healthy women. ATV, EE, PK, RTV
2009 Association between efficacy and body weight or body mass index for two low-dose oral contraceptives. BMI, CI, EE, NETA, RR
2009 Scheduled and unscheduled bleeding patterns with two combined hormonal contraceptives: application of new recommendations for standardization. EE, NETA
2008 Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives. BTB/S, EE
2007 Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use. EE, OCs
10  2006 Effects of an oral contraceptive (norgestimate/ethinyl estradiol) on bone mineral density in adolescent females with anorexia nervosa: a double-blind, placebo-controlled study. AN, BMD, DXA, EDNOS, EE, LS, OC
11  2006 Effects of E2 and E2/norgestimate hormone therapy on elevated baseline lipids. HDL-C, LDL-C, TC
12  2003 An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells. 19NT, APase, AR, ER, LNG, NETA, NOMAC, PgR
13  2003 Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea. BCE, Cr, EE
14  2003 Efficacy, safety and cycle control of five oral contraceptive regimens containing norgestimate and ethinyl estradiol. BBS, EE
15  2003 Serum distribution of the major metabolites of norgestimate in relation to its pharmacological properties. EE, LNG, NGMN, NPB, OC, SHBG
16  2003 The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study. DSG, GSD, LNG, VTE
17  2002 Clinical comparative study of oral contraceptives containing 30 microg ethinylestradiol/150 microg levonorgestrel, and 35 microg ethinylestradiol/250 microg norgestimate in Thai women. EE, LNG
18  2002 Intermittent progestin administration as part of hormone replacement therapy: long-term comparison between estradiol 1 mg combined with intermittent norgestimate and estradiol 2 mg combined with constant norethisterone acetate. HRT, NETA
19  2001 Constant estrogen, intermittent progestogen vs. continuous combined hormone replacement therapy: tolerability and effect on vasomotor symptoms. HRT, NETA
20  2001 Norgestimate. From the laboratory to three clinical indications. EE, HRT, OC
21  2000 Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy. HDL-C, HDL2-C, NETA
22  2000 Estradiol 17beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees. LNG, MPA, Pg
23  2000 Hemostatic effects of third- and second-generation oral contraceptives: absence of a causal mechanism for a difference in risk of venous thromboembolism. APC, DSG, ETP, FVII, GSD, LNG, OCs, VTE
24  1999 Clinical comparison of triphasic norgestimate/35 micrograms ethinyl estradiol and monophasic norethindrone acetate/20 micrograms ethinyl estradiol. Cycle control, lipid effects, and user satisfaction. BTB/BTS, EE, NETA, OC
25  1999 Determination of norgestimate and its metabolites in human serum using high-performance liquid chromatography with tandem mass spectrometric detection. 17-DA-NGM, 3-keto-NGM, HPLC, MS-MS, NGL
26  1999 Effect of a unique constant-estrogen, pulsed-progestin hormone replacement therapy containing 17beta-estradiol and norgestimate on endometrial histology. ---
27  1999 Efficacy and safety of a constant-estrogen, pulsed-progestin regimen in hormone replacement therapy. ---
28  1992 Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive. EE, OCs
29  1992 Selectivity and minimal androgenicity of norgestimate in monophasic and triphasic oral contraceptives. EE
30  1990 Efficacy and clinical profile of a new oral contraceptive containing norgestimate. U.S. clinical trials. EE, HDL, LDL, OC
31  1990 [Clinical evidence of the minimal androgenic activity of norgestimate]. HDL, LDL
32  1989 Clinical evidence of the minimal androgenic activity of norgestimate. CHD, HDL, LDL, OCs, SHBG